SILBERSTEIN DAVID S. enters LANTERN PHARMA INC. with 1.04M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 6/10/2020ACC: 0001213900-20-014626
Director10% Owner
Since Jun 2020
1.04M
Baseline shares
0.00
Direct ownership
0 positions
5.10K
Derivative underlying
1 instrument
1
Security positions
1.04M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.04M
Total
1.04M indirect1.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.04M | Indirect |
| Total | 1.04M | 1.04M indirect |
Derivative Holdings1
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
5.10K
Shares owned
N/A
Exercise price
1.03
Expiration
—
Exercise window
—
Total
Underlying
5.10K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 1.03 | — | — | 5.10K | N/A |
| Total | 5.10K | 0.00 | ||||